Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation Article

Molitoris, Jason K, Rao, Yuan James, Patel, Rajal A et al. (2017). Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation . Journal of Neuro-Oncology, 134(2), 331-338. 10.1007/s11060-017-2529-2

cited authors

  • Molitoris, Jason K; Rao, Yuan James; Patel, Rajal A; Kane, Liam T; Badiyan, Shahed N; Gittleman, Haley; Barnholtz-Sloan, Jill S; Bentzen, Soren M; Kruser, Tim J; Huang, Jiayi; Mehta, Minesh P

sustainable development goals

authors

publication date

  • September 1, 2017

published in

keywords

  • Clinical Neurology
  • Glioblastoma
  • IDH1
  • Life Sciences & Biomedicine
  • MUTATIONS
  • NEWLY-DIAGNOSED GLIOBLASTOMA
  • Neurosciences & Neurology
  • Nomogram
  • O6-Methylguanine-DNA methyltransferase
  • Oncology
  • RADIATION
  • RADIOTHERAPY
  • RANDOMIZED PHASE-III
  • SURVIVAL
  • Science & Technology
  • Survival
  • TEMOZOLOMIDE
  • TRIAL

Digital Object Identifier (DOI)

start page

  • 331

end page

  • 338

volume

  • 134

issue

  • 2